Orient EuroPharma Co., Ltd. (TPEX:4120)
44.50
-0.20 (-0.45%)
At close: Dec 3, 2025
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.89 billion as of December 5, 2025. Its market cap has decreased by -10.66% in one year.
Market Cap
3.89B
Enterprise Value
5.72B
Revenue
4.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
44.50
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.89B, an increase of 455.16%. That is a compound annual growth rate of 8.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Lin BioScience | 32.35B |
| Center Laboratories | 27.88B |